Kwan Ho Tang
Rutgers, The State University of New Jersey(US)University Hospital, Newark(US)AstraZeneca (Netherlands)(NL)The Affiliated Yongchuan Hospital of Chongqing Medical University(CN)AstraZeneca (United States)(US)Chongqing Medical University(CN)
Publications by Year
Research Areas
Protein Tyrosine Phosphatases, Cancer Cells and Metastasis, Peptidase Inhibition and Analysis, Lung Cancer Treatments and Mutations, Prostate Cancer Treatment and Research
Most-Cited Works
- → CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation(2011)587 cited
- → Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations(2008)454 cited
- → PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer(2020)386 cited
- → miR-130b Promotes CD133+ Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1(2010)384 cited
- → SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models(2018)306 cited
- → CD133+ liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling(2011)256 cited